Literature DB >> 34379454

Cumulative radiation doses due to nuclear medicine examinations: a systematic review.

Marco Brambilla1,2, Agnieszka Kuchcińska3, Roberta Matheoud2, Alfredo Muni4.   

Abstract

OBJECTIVES: To systematically review the published data regarding the cumulative exposure to radiation in selected cohorts of adults or paediatric patients due to diagnostic nuclear medicine examinations.
METHODS: We conducted PubMed/Medline searches of peer-reviewed papers on cumulated effective dose (CED) from diagnostic nuclear medicine procedures published between 01 January 2010 until 31 January 2021. Studies were considered eligible if the contribution of nuclear medicine examinations to total CED was >10%. Studies reporting cumulative doses in a single episode of care or in a limited time (≤1 year) were excluded. The main outcomes for which data were sought were the CED accrued by patients, the period in which the CED was accrued, the percentage of patients with CED > 100 mSv and the percentage contribution due to nuclear medicine procedures to the overall CED.
RESULTS: The studies included in the synthesis were 18 which enrolled a total of 1,76,371 patients. Eleven (1,757 patients), three (1,74,079 patients) and four (535 patients) were related to oncological, cardiologic and transplanted patients, respectively. All the studies were retrospective; some of the source materials referred to small number of patients and some of the patients were followed for a short time. Not many studies accurately quantified the contribution of nuclear medicine procedures to the overall radiation exposure due to medical imaging. Finally, most of the studies covered an observation period which extended mainly in the 2000-2010 decade.
CONCLUSIONS: There is a need of prospective, multicentric studies enrolling a greater number of patients, followed for longer period in selected groups of patients to fully capture the cumulative exposure to radiation in these settings. ADVANCES IN KNOWLEDGE: This systematic review allows to identify selected group of patients with a specific health status in which the cumulated exposure to radiation may be of concern and where the contribution of nuclear medicine procedures to the total CED is significant.

Entities:  

Mesh:

Year:  2021        PMID: 34379454      PMCID: PMC9328057          DOI: 10.1259/bjr.20210444

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  47 in total

1.  Ionizing radiation exposure as a result of diagnostic imaging in patients with lymphoma.

Authors:  M P Crowley; S B O'Neill; B Kevane; D C O'Neill; J A Eustace; M R Cahill; B Bird; M M Maher; K O'Regan; D O'Shea
Journal:  Clin Transl Oncol       Date:  2015-08-26       Impact factor: 3.405

2.  Paediatric radiopharmaceutical administration: harmonization of the 2007 EANM paediatric dosage card (version 1.5.2008) and the 2010 North American consensus guidelines.

Authors:  Michael Lassmann; S Ted Treves
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-06       Impact factor: 9.236

3.  Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies.

Authors:  Mark P Little; Richard Wakeford; David Borrego; Benjamin French; Lydia B Zablotska; M Jacob Adams; Rodrigue Allodji; Florent de Vathaire; Choonsik Lee; Alina V Brenner; Jeremy S Miller; David Campbell; Mark S Pearce; Michele M Doody; Erik Holmberg; Marie Lundell; Siegal Sadetzki; Martha S Linet; Amy Berrington de González
Journal:  Lancet Haematol       Date:  2018-07-17       Impact factor: 18.959

4.  Comparison of effective radiation doses from X-ray, CT, and PET/CT in pediatric patients with neuroblastoma using a dose monitoring program.

Authors:  Yeun Yoon Kim; Hyun Joo Shin; Myung Joon Kim; Mi-Jung Lee
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

5.  Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy.

Authors:  Neetha Gandikota; Sidonie Hartridge-Lambert; Jocelyn C Migliacci; Joachim Yahalom; Carol S Portlock; Heiko Schöder
Journal:  Cancer       Date:  2015-03-04       Impact factor: 6.860

6.  Pediatric Hodgkin lymphoma: are we over-scanning our patients?

Authors:  N Rathore; H M Eissa; J F Margolin; H Liu; M F Wu; T Horton; K Kamdar; Z Dreyer; P Steuber; K R Rabin; M Redell; C E Allen; K L McClain; R P Guillerman; C M Bollard
Journal:  Pediatr Hematol Oncol       Date:  2012-05-25       Impact factor: 1.969

7.  Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction.

Authors:  Mark J Eisenberg; Jonathan Afilalo; Patrick R Lawler; Michal Abrahamowicz; Hugues Richard; Louise Pilote
Journal:  CMAJ       Date:  2011-02-07       Impact factor: 8.262

8.  Ionizing radiation exposure among kidney transplant recipients due to medical imaging during the pretransplant evaluation.

Authors:  Kim N Nguyen; Anup M Patel; Francis L Weng
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-07       Impact factor: 8.237

9.  Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma.

Authors:  R A J Nievelstein; H M E Quarles van Ufford; T C Kwee; M B Bierings; I Ludwig; F J A Beek; J M H de Klerk; W P Th M Mali; P W de Bruin; J Geleijns
Journal:  Eur Radiol       Date:  2012-04-27       Impact factor: 5.315

10.  Multinational data on cumulative radiation exposure of patients from recurrent radiological procedures: call for action.

Authors:  Marco Brambilla; Jenia Vassileva; Agnieszka Kuchcinska; Madan M Rehani
Journal:  Eur Radiol       Date:  2019-12-02       Impact factor: 5.315

View more
  1 in total

1.  Contemporary issues in radiation protection in medical imaging: introductory editorial.

Authors:  Madan M Rehani; Zoe Brady
Journal:  Br J Radiol       Date:  2021-10       Impact factor: 3.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.